Trial Profile
Phase I/II study of Zevalin with CHOP-R/CHOP in treatment of DLBCL
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 02 Oct 2006
Price :
$35
*
At a glance
- Drugs Ibritumomab tiuxetan (Primary) ; Cyclophosphamide; Doxorubicin; Prednisolone; Rituximab; Vincristine
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 02 Oct 2006 New trial record.